Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment

PLATINUM BASED VERSUS ANTHRACYCLIN BASED NEOADJUVANT CHEMOTHERAPY IN NONMETASTATIC TRIPLE NEGATIVE BREAST CANCER (TNBC) PATIENTS

Outcome of Anthracycline versus Taxane Based Regimens on Different Metastatic Sites in Breast Cancer

Impact of Different Lines of Palliative Chemotherapy in Patients with Metastatic Breast Cancer

Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast cancer

Updates in the Management of Triple Negative BC: Review article

EFFECTIVENESS AND SAFETY OF PLATINUM BASED AGENTS NEOADJUVANT CHEMOTHERAPY ON PATHOLOGICAL COMPLETE RESPONSE IN TRIPLE NEGATIVE BREAST CANCER PATIENTS (A RETROSPECTIVE STUDY)

Evaluation of Concurrent Adjuvant Chemotherapy Paclitaxel and Radiotherapy in Breast Conserving Management of Early Breast Cancer

The validity of giving adjuvant capecitabine after standard anthracycline and/or taxanes based neo-/adjuvant chemotherapy in early triple-negative breast cancer patients: An Egyptian prospective multicentric phase III trial

Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study